| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $280.3M | -12.9% |
| R&D Expense | $81.9M | -9.4% |
| SG&A Expense | $117.9M | +17.4% |
| Operating Income | -$203.4M | -163.3% |
| Pre-tax Income | -$190.1M | -149.4% |
| Income Tax | $141K | -62.8% |
| Net Income | -$190.3M | -148.4% |
| EPS (Basic) | -$3.54 | -145.8% |
| EPS (Diluted) | -$3.54 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $82.2M | -8.6% |
| Short-term Investments | $153.2M | -24.6% |
| Accounts Receivable | $51.1M | -23.0% |
| Inventory | $19.5M | +1.2% |
| Current Assets | $313.7M | -19.1% |
| Total Assets | $466.8M | -14.0% |
| Current Liabilities | $78.1M | +2.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.4M | +27.1% |
| Investing Cash Flow | $40.4M | +117.7% |
| Financing Cash Flow | -$29.6M | -552.8% |
| -145.8% |
| Total Liabilities |
| $205.5M |
| +83.3% |
| Stockholders' Equity | $261.3M | -39.4% |